Amgen, Inc. (AMGN)
Amgen Market Cap: 174.70B for Jan. 14, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Gilead Sciences, Inc. | 151.97B |
| Johnson & Johnson | 523.30B |
| Eli Lilly & Co. | 954.42B |
| Merck & Co., Inc. | 269.15B |
| Regeneron Pharmaceuticals, Inc. | 80.05B |
Market Cap Related Metrics
| PE Ratio | 25.08 |
| PS Ratio | 4.895 |
| PEG Ratio | 0.3822 |
| Price to Book Value | 18.16 |
| Price to Free Cash Flow | 15.22 |
| Price | 324.43 |
| Earnings Yield | 3.99% |
| PEGY Ratio | 0.3658 |
| Operating PE Ratio | 17.14 |
| Normalized PE Ratio | 21.62 |